Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
1 Semaglutide may cause fetal harm and should be discontinued at least two months before a planned pregnancy
If you experience any suspected side effects whilst participating in a retatrutide trial or after stopping treatment, these should be reported to the trial team and, where appropriate, via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk), which enables reporting of suspected adverse reactions to medicines and vaccines in the UK
The main trade names of Semaglutide are Ozempic, Wegovy, and Rybelsus
Some combination products, such as Xultophy, contain both a long-acting insulin and a GLP-1 in the same pen
US$ 21.22
US$ 29.86
US$ 22.75
US$ 29.72
US$ 21.28
